Inozyme Pharma Inc

NASDAQ:INZY   3:57:37 PM EDT
15.33
-0.52 (-3.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Inozyme Pharma Inc Stock, NASDAQ:INZY

321 Summer Street, Suite 400, Boston, Massachusetts 02210
United States of America
Phone: +1.857.330.4340
Number of Employees:

Description

Inozyme Pharma engages in the research and development of novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue, and skeleton. Its lead product candidate is INZ-701, which is designed to correct a defect in the mineralization pathway caused by ENPP1 and ABCC6 deficiencies. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.